Celcuity Eyeing Cancer Treatment Riddle. Stock Flys 534% This Year.

Published 2 days ago • Nov 6, 2025 at 3:03 PM • Neutral

Auto

Celcuity hopes to "solve a 20-year riddle" in cancer treatment. The journey has sent the biotech stock flying as much as 534% this year.

Continue Reading

View Comments

More News

2 AI Stocks That Could Go Parabolic

1 hour ago Positive

More Drugs to Fight High Cholesterol Are Emerging

1 hour ago Positive

Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week

2 hours ago Neutral

Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

2 hours ago Negative

UPS Grounds MD-11 Fleet After Kentucky Cargo Jet Crash. What to Know.